Cardiovascular disease in patients with ankylosing spondylitis
Main Authors: | Andrei Petrovich Rebrov, I Z Gaidulova, D A Poddubnyi |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2012-04-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1577 |
Similar Items
-
Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: Results of a 12-week, prospective, open-label, pilot (METALL) study
by: I Z Gaydukova, et al.
Published: (2015-05-01) -
CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION
by: D. A. Poddubnyy, et al.
Published: (2016-01-01) -
Osteophytes in the Joints of Patients with Ankylosing Spondylitis: Manifestation of Osteoarthritis or Underlying Disease?
by: K. D. Dorogoykina, et al.
Published: (2020-05-01) -
Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
by: Erdinç Hatipsoylu, et al.
Published: (2019-09-01) -
Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)